About this item:

90 Views | 47 Downloads

Author Notes:

We are incredibly grateful to participating families and colleagues who have made this research possible. Sequencing services were provided by the Center for Inherited Disease Research (CIDR). CIDR is fully funded through a federal contract from the National Institutes of Health to The Johns Hopkins University, contract number HHSN268201700006I. Patient recruitment, assembly of phenotypic information, sequencing services, and data analysis were supported by National Institutes of Health (NIH) grants: X01-HG010835 (EL), R01-DE016148 (MM, SW), R01-DE030342 (EL), R01-DE011931 (JH), R01-DE028300 (AB), R01-DE014581 (TB), R37-DE008559 (JM), R00-DE024571 (CB), S21-MD001830 (CB) U54-GM133807 (CB) , T32-GM008490 (KR), F31-DE032588 (KR), R56-DE030917 (RL), F32-DE032260 (SWC). Some of this work was supported through cooperative agreements under PA 96043 from the Centers for Disease Control and Prevention to the Centers for Birth Defects Research and Prevention participating in the NBDPS. The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention or the California Department of Public Health. This article was prepared while Trenell J. Mosley was employed at Emory University. The opinions expressed in this article are the author’s own and do not reflect the view of the National Institutes of Health, the Department of Health and Human Services, or the United States government. This study makes use of data generated by the DECIPHER community. A full list of centers who contributed to the generation of the data is available from https://deciphergenomics.org/about/stats and via email from gro.scimonegrehpiced@tcatnoc. Funding for the DECIPHER project was provided by Wellcome [grant number WT223718/Z/21/Z].

The authors declare no competing interests.

Subjects:

Research Funding:

Sequencing services were provided by the Center for Inherited Disease Research (CIDR). CIDR is fully funded through a federal contract from the National Institutes of Health to The Johns Hopkins University, contract number HHSN268201700006I. Patient recruitment, assembly of phenotypic information, sequencing services, and data analysis were supported by National Institutes of Health (NIH) grants: X01-HG010835 (EL), R01- DE016148 (MM, SW), R01-DE030342 (EL), R01-DE011931 (JH), R01-DE028300 (AB), R01-DE014581 (TB), R37-DE008559 (JM), R00-DE024571 (CB), S21MD001830 (CB) U54GM133807 (CB), T32GM008490 (KR), F31DE032588 (KR). Some of this work was supported through cooperative agreements under PA 96043 from the Centers for Disease Control and Prevention to the Centers for Birth Defects Research and Prevention participating in the NBDPS. The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention or the California Department of Public Health. This article was prepared while Trenell J. Mosley was employed at Emory University. The opinions expressed in this article are the author's own and do not reflect the view of the National Institutes of Health, the Department of Health and Human Services, or the United States government. This study makes use of data generated by the DECIPHER community. A full list of centres who contributed to the generation of the data is available from https://deciphergenomics.org/about/stats and via email from contact{at}deciphergenomics.org. Funding for the DECIPHER project was provided by Wellcome (grant number WT223718/Z/21/Z).

Keywords:

  • novel associations
  • Orofacial clefts (OFCs)

Trio-based GWAS identifies novel associations and subtype-specific risk factors for cleft palate

Show all authors Show less authors

Tools:

Journal Title:

medRxiv

Volume:

Volume 2023

Publisher:

Type of Work:

Article | Preprint: Prior to Peer Review

Abstract:

Orofacial clefts (OFCs) are the most common craniofacial birth defects and are often categorized into two etiologically distinct groups: cleft lip with or without cleft palate (CL/P) and isolated cleft palate (CP). CP is highly heritable, but there are still relatively few established genetic risk factors associated with its occurrence compared to CL/P. Historically, CP has been studied as a single phenotype despite manifesting across a spectrum of defects involving the hard and/or soft palate. We performed GWAS using transmission disequilibrium tests using 435 case-parent trios to evaluate broad risks for any cleft palate (ACP, n=435), as well as subtype-specific risks for any cleft soft palate (CSP, n=259) and any cleft hard palate (CHP, n=125). We identified a single genome-wide significant locus at 9q33.3 (lead SNP rs7035976, p=4.24x10−8) associated with CHP. One gene at this locus, angiopoietin-like 2 (ANGPTL2), plays a role in osteoblast differentiation. It is expressed in craniofacial tissue of human embryos, as well as in the developing mouse palatal shelves. We found 19 additional loci reaching suggestive significance (p<5x10−6), of which only one overlapped between groups (chromosome 17q24.2, ACP and CSP). Odds ratios (ORs) for each of the 20 loci were most similar across all three groups for SNPs associated with the ACP group, but more distinct when comparing SNPs associated with either the CSP or CHP groups. We also found nominal evidence of replication (p<0.05) for 22 SNPs previously associated with cleft palate (including CL/P). Interestingly, most SNPs associated with CL/P cases were found to convey the opposite effect in those replicated in our dataset for CP only. Ours is the first study to evaluate CP risks in the context of its subtypes and we provide newly reported associations affecting the broad risk for CP as well as evidence of subtype-specific risks.
Export to EndNote